Refine by
Applications
- Solution for Clinical Trials
- Solution for Access to Investigational Medicines
- Diagnostic Solutions for Lung Cancer
- Liquid Biopsy Solutions for Breast Cancer
- Diagnostic Solutions for Colorectal Cancer
- Radioactive Drugs for Diagnostics
- Radioactive Drugs for Therapeutics
- Drug Dolution for Liver Metastases
- Drug Dolution for Gastric Cancer
- microbiota for Clinical Studies
- Actionable Molecular Diagnostic System for Physicians
- Intraoperative Radiation Therapy (IORT) System - Electron Therapy for Skin Cancer
- Intraoperative Radiation Therapy (IORT) System for Flash Radiotherapy
- Intraoperative Radiation Therapy (IORT) System for Pancreatic Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Breast Cancer Treatment
- Intraoperative Radiation Therapy (IORT) System for Single-Fraction APBI
- Intraoperative Radiation Therapy (IORT) System for Surgical Oncologists
- Intraoperative Radiation Therapy (IORT) System for Radiation Oncologists
- Intraoperative Radiation Therapy (IORT) System for Hospital Administrators
- Nuclear Medicine for Therapy
- Nuclear Medicine for Theragnostics
Cancer Cell Equipment & Supplies
1,366 equipment items found
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation depth of MCF7 breast cancer cells in the Mimetix scaffold after 4 days of culture (nuclei stained with TO-PRO-3, blue). The video below shows a Z-stack (slices ...
Manufactured by:The Electrospinning Company Ltd. based inDidcot, UNITED KINGDOM
Images taken using a Nikon Eclispe C1 confocal microscope. HepG2 liver cells were grown for 21 days in the Mimetix scaffold. Cells are stained with DAPI and actin; fibres are electrospun together with Rhodamine 6G (a and b). Cancer cells form a 3D network inside the scaffold (c), use the fibres to support themselves (d) and ...
Manufactured by:BriaCell Therapeutics Corp. based inWest Vancouver, BRITISH COLUMBIA (CANADA)
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We hypothesize that Bria-IMT™/Bria-OTS™, exert their action by stimulating the antigen-presentation system (i.e. the system that presents antigen material on ...
Manufactured by:Filtricine, Inc. based inSanta Clara, CALIFORNIA (USA)
The hyperactive metabolism of cancer cells is extensively modified to support their unsustainable consumption of nutrients, which is what allows cancer cells to reproduce rapidly. Yet cancer cells lose their ability to make certain nutrients on their own like healthy cells do. ...
Manufactured by:Mol Scientific based in, CHINA
Mol Scientific offer high-quality Cancer cell proliferation inhibitor peptide product(MPE0003430). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly competitive prices. ...
Manufactured by:Filtricine, Inc. based inSanta Clara, CALIFORNIA (USA)
Filtricine’s Innovative Technology Restricts Nutritional Support to Cancer Cells. Our strategy is to eliminate cancer cells’ access to non-essential amino acids, which the cancer cells require for growth. Our first technology is used in the development of exclusive replacement meals ...
Manufactured by:OncoVITA based inParis, FRANCE
Oncovita’s MeasovirTM proprietary platform relies on a DNA plasmid vector that expresses a modified measles Schwarz virus antigenome able to generate recombinant viruses by using a clonal reverse genetics system. This versatile plug-and-play platform allows producing new viruses expressing very large amounts of additional genetic ...
Manufactured by:Jubilant Therapeutics Inc. based inBedminster, NEW JERSEY (USA)
Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
Manufactured by:Senti Biosciences based inSouth San Francisco, CALIFORNIA (USA)
Pursuing an Unmet Need in the Treatment of CRC - SENTI-401 is designed to more precisely target and eliminate colorectal cancer (CRC) cells while sparing healthy cells elsewhere in the body. Our vision is a potential medicine that more effectively treats patients with colorectal ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
Human (Parental) Brain Cancer Stem Cell (Plated cells are also available). 120 Population doublings or up to 12 passages. One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in dry-ice. Cell Cultures from single donors, 1000 different ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
K-NK00X: Kiadis is evaluating preclinical programs with K-NK-cell therapies for the treatment of hematologic and solid ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
K-NK002: A phase 2 clinical study evaluating haplo-identical NK cells to prevent post-transplant relapse in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This study was designed based on promising clinical proof-of-concept data from MD Anderson Cancer Center. The phase 2 trial for K-NK002 will be conducted in collaboration with ...
Manufactured by:Kiadis Pharma NV based inAmsterdam, NETHERLANDS
K-NK003: A phase 1 study evaluating NK cells as a treatment for patients with relapse and refractory acute myeloid leukemia (AML). This study was designed based on promising clinical proof-of-concept data from two studies, one at MD Anderson Cancer Center and one at HCPA in ...
Manufactured by:Eutilex Co.,Ltd. based inSeoul, SOUTH KOREA
4th generation GPC3 CAR-T shows better efficacy compared to 2nd generation GPC3 CAR-T; Shows better efficacy for tumor clearance than 2nd generation GPC3 CAR-T in vivo; Clear anti-cancer efficacy in an orthotopic model; Smaller number of 4th generation GPC3 CAR-T required than other groups to remove ...
Manufactured by:Lineage Cell Therapeutics, Inc. based inCarlsbad, CALIFORNIA (USA)
VAC2 is an allogeneic, or non-patient specific, cancer vaccine candidate designed to stimulate patient immune responses to telomerase which is commonly expressed in cancerous cells but not in normal adult cells. VAC2, which is produced from our pluripotent cell technology using a directed differentiation ...
Manufactured by:Vitro Biopharma based inGolden, COLORADO (USA)
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen (1% - 5% O2). Available for research ...
Manufactured by:Vitro Biopharma based inGolden, COLORADO (USA)
Human Ovarian Serous Cancer Associated Fibroblasts. Cryopreserved at a low passage. High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). ...
Manufactured by:Vitro Biopharma based inGolden, COLORADO (USA)
Human Lung Adenocarcinoma Cancer Associated Fibroblasts; Cryopreserved at a low passage; Stage: III; High passage capabilities; Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability); Able to grow in low oxygen (1% - 5% O2); Available for ...
Manufactured by:HEALIOS K.K. based inTokyo, JAPAN
Cancer is the leading cause of death in Japan, with approximately 90% of those deaths said to be caused by solid ...
by:Cymit Química S.L. based inBarcelona, SPAIN
4-Methylumbelliferyl lignocerate is a synthetic fatty acid that inhibits the growth of cancer cells. It has been shown to have an inhibitory effect on breast cancer cell lines, such as MDA-MB-231 and MCF-7. ...